Medical materials

Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Joint Health Outcomes With Efanesoctocog Alfa Prophylaxis for Patients With Severe Hemophilia A: Third Interim Analysis of the Phase 3 XTEND-ed Study

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, María Teresa Álvarez Román, Liane Khoo, Nobuaki Suzuki, Graham Neill, Linda Bystrická, Meredith Foster, Elena Santagostino, Sriya Gunawardena, Robert Klamroth

Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Baseline Characteristics of Patients Switching to Prophylactic Efanesoctocog Alfa Therapy Evaluated for Joint Health in Hemophilia A in Taiwan (PROTECT-ALT Study)

Yeu-Chin Chen, Ming-Ching Shen, Cheng-Wei Huang, Hung Chang, Jiaan-Der Wang, Sheng-Chieh Chou, Ching-Tien Peng, Chih-Cheng Hsiao, Chia-Yau Chang, Te-Fu Weng, Tong-Ling Chien, Ching-Min Chang, Shyh-Shin Chiou

Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Interim analysis of the A-MORE real-world study: 4-year treatment outcomes with a recombinant factor VIII Fc in the overall and non-severe populations

Jan Astermark, Antonio Coppola, Swee Wenning, Ruben Berrueco, Ester Zapotocka, Andreu Schoenenberger López, Eva Bednar, Stefan Lethagen

Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Perioperative management of Haemophilia B: A HaemSTAR UK-wide audit

Jayna Mistry, Sarah Idris, Thomas Flamini, Srdan Rogosic, Bradley Dixon, Rosemary Barker, Elizabeth Ryan, Abigail Wright, Asiya Nur, Kate Burley, Yen Yeo, Samuel Harvey, Arpan Doshi, HaemSTAR Collaborators, Philip Nicolson, Jaspal Dhir, Charles Hay, Gillian Lowe, Richard Buka

Publication
  • ISTH •
  • 13 July, 2026 •
  • •

Joint Health in Patients with Severe Haemophilia A Treated with Efanesoctocog Alfa: 12-Month Interim Results from the FREEDOM Study

Christoph Königs, Dominique Desprez, María Teresa Álvarez Román, Cristina Santoro, Josefin Blomkvist, Jenny Björkqvist, Markus Fusser, Jan Astermark, Pål Andre Holme

Publication
  • ISTH •
  • 13 July, 2026 •
  • •

REFINE study protocol: Real-world outcomes of EFanesoctocog alfa IN Central and Eastern Europe Study Design

Ana Boban, Atanas Banchev, Barbara Faganel-Kotnik, Radomíra Hrdličková, Jan Rajnoch, Ester Zapotocka, Irena Preložnik Zupan

Publication
  • ISTH •
  • 13 July, 2026 •
  • •

Retrospective, Real-World Study of Annual Bleeding Rate Changes Reported in the Microhealth Digital App by Patients with Hemophilia A Transitioning to Efanesoctocog Alfa

Meera Chitlur, Adam Giermasz, Maissaa Janbain, Jonathan C. Roberts, Angela C. Weyand, Angela Styhler, Marc Lara, Andrew Wilson, Arta Subagiarta, Duygu Bozkaya, Sanjay Ahuja

Publication
  • ISTH •
  • 13 July, 2026 •
  • •

Final Surgery Data from B-MORE: A 24-Month, Prospective, Non-Interventional Study of the Real-World Effectiveness and Usage of rFIXFc in Haemophilia B

Heidi Glosli, Anna Olsson, Saket Badle, Flora Peyvandi, Håkan Malmström, Eva Bednar, Stefan Lethagen

Sign up for alerts